Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients von Jie, H-B, Gildener-Leapman, N, Li, J, Srivastava, R M, Gibson, S P, Whiteside, T L, Ferris, R L

Volltext

EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1–TUFM protein complex von Lei, Y, Kansy, B A, Li, J, Cong, L, Liu, Y, Trivedi, S, Wen, H, Ting, J P-Y, Ouyang, H, Ferris, R L

Volltext

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells von Sun, Q, Ming, L, Thomas, S M, Wang, Y, Chen, Z G, Ferris, R L, Grandis, J R, Zhang, L, Yu, J

Volltext

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study von Ferris, R.L., Haddad, R., Even, C., Tahara, M., Dvorkin, M., Ciuleanu, T.E., Clement, P.M., Mesia, R., Kutukova, S., Zholudeva, L., Daste, A., Caballero-Daroqui, J., Keam, B., Vynnychenko, I., Lafond, C., Shetty, J., Mann, H., Fan, J., Wildsmith, S., Morsli, N., Fayette, J., Licitra, L.

Volltext

Insights from Studies with Oral Cleft Genes Suggest Associations between WNT-pathway Genes and Risk of Oral Cancer von Andrade Filho, P.A., Letra, A., Cramer, A., Prasad, J.L., Garlet, G.P., Vieira, A.R., Ferris, R.L., Menezes, R.

Volltext

Response assessment by combined PET–CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy von Passero, V.A., Branstetter, B.F., Shuai, Y., Heron, D.E., Gibson, M.K., Lai, S.Y., Kim, S.W., Grandis, J.R., Ferris, R.L., Johnson, J.T., Argiris, A.

Volltext

Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma von Moskovitz, J.M., Ferris, R.L.

Volltext

Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer von Argiris, A., Karamouzis, M.V., Smith, R., Kotsakis, A., Gibson, M.K., Lai, S.Y., Kim, S., Branstetter, B.F., Shuai, Y., Romkes, M., Wang, L., Grandis, J.R., Ferris, R.L., Johnson, J.T., Heron, D.E.

Volltext

Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis von Lang Kuhs, K.A., Faden, D.L., Chen, L., Smith, D.K., Pinheiro, M., Wood, C.B., Davis, S., Yeager, M., Boland, J.F., Cullen, M., Steinberg, M., Bass, S., Wang, X., Liu, P., Mehrad, M., Tucker, T., Lewis, J.S., Ferris, R.L., Mirabello, L.

Volltext

Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers von Gokhale, A. S., McLaughlin, B. T., Flickinger, J. C., Beriwal, S., Heron, D. E., Ferris, R. L., Johnson, J., Gibson, M. K., Argiris, A., Smith, R. P.

Volltext

Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive c... von Ling, D.C., MD, Chapman, B.V., MD, Kim, J., MD, Choby, G.W., MD, Kabolizadeh, P., MD, PhD, Clump, D.A., MD, PhD, Ferris, R.L., MD, PhD, FACS, Kim, S., MD, Beriwal, S., MD, Heron, D.E., MD, FACRO, FACR, Duvvuri, U., MD, PhD

Volltext

Immune biomarkers of anti-EGFR monoclonal antibody therapy von Trivedi, S., Concha-Benavente, F., Srivastava, R.M., Jie, H.B., Gibson, S.P., Schmitt, N.C., Ferris, R.L.

Volltext

Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma von Rath, T J, Narayanan, S, Hughes, M A, Ferris, R L, Chiosea, S I, Branstetter, 4th, B F

Volltext

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer von Argiris, A., Bauman, J.E., Ohr, J., Gooding, W.E., Heron, D.E., Duvvuri, U., Kubicek, G.J., Posluszny, D.M., Vassilakopoulou, M., Kim, S., Grandis, J.R., Johnson, J.T., Gibson, M.K., Clump, D.A., Flaherty, J.T., Chiosea, S.I., Branstetter, B., Ferris, R.L.

Volltext

Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer von Ferris, R.L., Geiger, J.L., Trivedi, S., Schmitt, N.C., Heron, D.E., Johnson, J.T., Kim, S., Duvvuri, U., Clump, D.A., Bauman, J.E., Ohr, J.P., Gooding, W.E., Argiris, A.

Volltext

Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer von McDermott, M, Hughes, M, Rath, T, Johnson, J T, Heron, D E, Kubicek, G J, Kim, S W, Ferris, R L, Duvvuri, U, Ohr, J P, Branstetter, B F

Volltext

Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors von Glisson, B., Leidner, R., Ferris, R.L., Powderly, J., Rizvi, N.A., Keam, B., Schneider, R., Goel, S., Ohr, J.P., Zheng, Y., Eck, S., Gribbin, M., Townsley, D.M., Chiou, V., Patel, S.P.

Volltext

Autocrine and Paracrine Chemokine Receptor 7 Activation in Head and Neck Cancer: Implications for Therapy von Wang, Jun, Seethala, Raja R., Zhang, Qing, Gooding, William, van Waes, Carter, Hasegawa, Hitoshi, Ferris, Robert L.

Volltext

Stimulatory and inhibitory signaling pathways of the T cell-APC interaction and the effect of TLR agonists on APCs von Kürten, C H L, Deuß, E, Lei, Y L, Höing, B, Kramer, B, Lang, S, Ferris, R L, Kansy, B A

Volltext

Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma von Lai, Stephen Y, Childs, Erin E, Xi, Sichuan, Coppelli, Francesca M, Gooding, William E, Wells, Alan, Ferris, Robert L, Grandis, Jennifer R

Volltext